西北医学与Vitestro合作推进自主机器人静脉采血技术-动脉网

Northwestern Medicine and Vitestro Collaborate to Advance Autonomous Robotic Phlebotomy

CISION 等信源发布 2025-03-19 20:00



可切换为仅中文







Collaboration to Address Global Staffing Shortages and Set a New Standard for Automated Diagnostic Blood Collection

协作应对全球人员短缺问题，为自动诊断性采血树立新标准

CHICAGO

芝加哥

and

和

SAN FRANCISCO

旧金山

，

March 19, 2025

2025年3月19日

/PRNewswire/ -- Northwestern Medicine,

/PRNewswire/ -- 西北医学，

Chicago's

芝加哥的

premier integrated academic health system, and Vitestro, a pioneer in autonomous robotic vascular access and diagnostic blood collection, today announced a multi-year collaboration to advance automation in phlebotomy and transform the patient experience.

首个综合学术健康系统和血管通路及诊断性血液采集自主机器人领域的先锋企业Vitestro今天宣布了一项多年合作，旨在推动采血自动化并改善患者体验。

As part of this collaboration, Northwestern Medicine will participate in a multicenter clinical trial validating the performance and safety of Vitestro's Aletta™—the world's first Autonomous Robotic Phlebotomy Device™ (ARPD™). The goal of the study is to generate key clinical evidence to support adoption of automated phlebotomy as a scalable solution for U.S.

作为此次合作的一部分，西北医学院将参与一项多中心临床试验，验证 Vitestro 的 Aletta™（世界上首个自主机器人静脉采血设备™ (ARPD™)）的性能和安全性。该研究的目标是生成关键的临床证据，以支持将自动静脉采血作为美国可扩展的解决方案。

hospital and outpatient blood draw centers..

医院和门诊抽血中心。

'At Northwestern Medicine, we are dedicated to pioneering innovations that elevate patient care and operational excellence,' said

“在西北医学，我们致力于开创提升患者护理和运营卓越性的创新，”

Gary A. Noskin

加里·A·诺斯金

, MD, senior vice president, Northwestern Memorial HealthCare, and president, Northwestern Medical Group. 'Our collaboration with Vitestro is a step forward in transforming diagnostic testing by automating venous blood collection. Through this relationship our goal is to improve efficiency, enhance sample integrity, and redefine the patient experience through cutting-edge technology.'.

医学博士，西北纪念医疗保健高级副总裁，西北医疗集团总裁。“我们与Vitestro的合作是通过自动化静脉采血来转变诊断测试的一步。通过这种合作关系，我们的目标是提高效率、增强样本完整性，并通过尖端技术重新定义患者体验。”

By automating and standardizing blood collection, this collaboration aims to:

通过自动化和标准化血液采集，此次合作旨在：

Address critical phlebotomy workforce shortages by providing a scalable, automated solution.

通过提供可扩展的自动化解决方案，解决关键的采血人员短缺问题。

Enhance operational efficiency and patient throughput in high-volume hospital outpatient settings.

提高高流量医院门诊环境中的运营效率和患者吞吐量。

Improve sample quality and integrity, reducing errors associated with manual venipuncture.

提高样本质量和完整性，减少与手动静脉穿刺相关的错误。

Expand access to high-quality blood collection while enhancing patient comfort and overall care.

扩大获得高质量血液采集的机会，同时提高患者的舒适度和整体护理水平。

'We are privileged to collaborate with Northwestern Medicine in setting a new standard for laboratory automation,' said

“我们有幸与西北医学合作，为实验室自动化树立新的标准，”

Brian Joseph

布莱恩·约瑟夫

, Co-founder of Vitestro. 'Vitestro's mission is to empower hospitals and laboratories with transformative robotic solutions that drive efficiency, improve clinical outcomes, and elevate the patient experience. This collaboration will further validate the role of automation in modernizing blood collection.'.

Vitestro联合创始人表示：“Vitestro的使命是通过变革性的机器人解决方案，为医院和实验室提供支持，提升效率、改善临床结果并优化患者体验。此次合作将进一步验证自动化在血液采集现代化中的作用。”

作为

Chicago's

芝加哥的

premier integrated academic health system, Northwestern Medicine offers patients access to world class, compassionate care at 11 hospitals and more than 200 diagnostic and ambulatory sites.

西北医学中心作为首个综合学术健康系统，为患者提供在11家医院和200多个诊断和门诊站点获取世界级、富有同情心的医疗服务的机会。

'Phlebotomy remains one of the last manual processes in laboratory medicine, and automation presents a pivotal opportunity to transform it,' said

“静脉采血仍然是实验室医学中最后一个手动操作的流程之一，而自动化提供了一个关键的机会来改变它，”

Gregory S. Retzinger

格雷戈里·S·雷辛格

, MD, PhD, Medical Director of Pathology Clinical Services, Northwestern Memorial Hospital. 'This collaboration goes beyond evaluating autonomous robotic phlebotomy — it has the potential to solve urgent staffing challenges and redefining the future of laboratory medicine.

，医学博士，病理临床服务医疗主任，西北纪念医院。 “这次合作不仅仅是评估自主机器人静脉采血——它有潜力解决紧迫的人员配置挑战，并重新定义实验室医学的未来。

'We are proud to partner with Northwestern Medicine's visionary leadership, who recognize the future in phlebotomy automation,' said

“我们为与西北医学中心富有远见的领导层合作感到自豪，他们认识到静脉采血自动化的未来，”

Bob Gerberich

鲍勃·格伯里希

, CCO of

，首席文化官（CCO）

North America

北美

at Vitestro. 'Their commitment, along with the work of our other U.S. clinical trial partners, will be instrumental in establishing a new standard in total laboratory workflow automation. This collaboration marks a defining moment in making autonomous blood collection an integral part of modern healthcare.'.

在Vitestro。‘他们与其他美国临床试验合作伙伴的努力，将会在建立全新的实验室全流程自动化标准中发挥关键作用。这次合作标志着自主采血成为现代医疗保健重要组成部分的决定性时刻。’

About Northwestern Medicine

关于西北医学中心

To learn more about Northwestern Medicine, please visit NM.org.

要了解有关西北医学的更多信息，请访问 NM.org。

About Vitestro

关于Vitestro

Vitestro is a global leader in medical robotics, headquartered in

维特斯特罗是医疗机器人领域的全球领导者，总部位于

the Netherlands

荷兰

, with deep expertise in engineering, robotics, and commercialization in both the U.S. and international markets. The company has developed and launched the world's first and only CE-marked Autonomous Robotic Phlebotomy Device™ (ARPD™), setting a new benchmark for diagnostic venous blood sampling. By integrating advanced robotics, artificial intelligence, and imaging technology, Vitestro delivers precision, efficiency, and an enhanced patient experience.

，公司在工程、机器人技术和美国及国际市场的商业化方面具有深厚的专业知识。该公司开发并推出了全球首个也是唯一获得CE认证的自主机器人静脉采血设备™（ARPD™），为诊断性静脉采血树立了新的标杆。通过整合先进的机器人技术、人工智能和成像技术，Vitestro实现了精准、高效，并提升了患者的体验。

While Aletta has not yet received FDA approval, Vitestro is actively preparing for regulatory approval in the U.S. and global expansion..

虽然Aletta尚未获得FDA批准，但Vitestro正在积极准备在美国的监管审批和全球扩张。

For more information, visit vitestro.com.

欲了解更多信息，请访问 vitestro.com。

SOURCE Vitestro

来源：Vitestro

WANT YOUR COMPANY'S NEWS

想要你公司的新闻吗

FEATURED ON PRNEWSWIRE.COM?

刊登在PRNEWSWIRE.COM上？

440k+